Components of the anti-Müllerian hormone signaling pathway in gonads

Molecular and Cellular Endocrinology

Volumn 211, Issue 1-2, 2003, Pages 9-14

  Di Clemente, N ^a   Josso, N ^a   Gouedard L ^a   Belville, C ^a  

^a INSERM   (France)

Author keywords

Activin receptor like kinase; Anti M llerian hormone; Anti M llerian hormone type II receptor; Gonads; M llerian inhibiting substance; Signaling pathway

Indexed keywords

ACTIVIN RECEPTOR; ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR 3; ACTIVIN RECEPTOR 6; BONE MORPHOGENETIC PROTEIN; MUELLERIAN INHIBITING FACTOR; RECEPTOR SUBTYPE; SMAD ANCHOR FOR RECEPTOR ACTIVATION; SMAD PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

CONFERENCE PAPER; GONAD DEVELOPMENT; HORMONAL REGULATION; HYPOPHYSIS GONAD SYSTEM; MECHANOTRANSDUCTION; MUELLERIAN DUCT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR INTRINSIC ACTIVITY; REPORTER GENE;

EID: 0344062588     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.09.005     Document Type: Conference Paper

References (30)

1. Allard S., Adin P., Gouédard L., di Clemente N., Josso N., Orgebin-Crist M.C., Picard J.Y., Xavier F. Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of β-catenin. Development. 127:2000;3349-3360.
2. Baarends W.M., van Helmond M.J.L., Post M., van der Schoot P.C.J.M., Hoogerbrugge J.W., de Winter J.P., Uilenbroek J.T.J., Karels B., Wilming L.G., Meijers J.H.C., Themmen A.P.N., Grootegoed J.A. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. Development. 120:1994;189-197.
3. Baarends X.M., Uilenbroek J.T.J., Kramer P., Hoogerbrugge J.W., Vanleeuwen E.C.M., Themmen A.P.N., Grootegoed J.A. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 136:1995a;4951-4962.
4. Baarends W.M., Hoogerbrugge J.W., Post M., Visser J.A., Derooij D.G., Parvinen M., Themmen A.P.N., Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat. Endocrinology. 136:1995b;5614-5622.
5. Behringer R.R., Finegold M.J., Cate R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell. 79:1994;415-425.
6. Carcamo J., Weis F.M.B., Ventura F., Wieser R., Wrana J.L., Attisano L., Massagué J. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor-β and activin. Mol. Cell. Biol. 14:1994;3810-3821.
7. Clarke T.R., Hoshiya Y., Yi S.E., Liu X.H., Lyons K.M., Donahoe P.K. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression. Mol. Endocrinol. 15:2001;946-959.
8. Dewulf N., Verschueren K., Lonnoy O., Moren A., Grimsby S., Vandespiegle K., Miyazono K., Huylebroeck D., ten Dijke P. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology. 136:1995;2652-2663.
9. di Clemente N., Wilson C.A., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.Y., Vigier B., Josso N., Cate R.L. Cloning, expression and alternative splicing of the receptor for anti-Müllerian hormone. Mol. Endocrinol. 8:1994;1006-1020.
10. Dutertre M., Gouédard L., Xavier F., Long W.Q., di Clemente N., Picard J.Y., Rey R. Ovarian granulosa cell tumors express a functional receptor for anti-Müllerian hormone in transgenic mice. Endocrinology. 142:2001;4040-4046.
11. Dutertre M., Rey R., Porteu A., Josso N., Picard J.Y. A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptor. Mol. Cell. Endocrinol. 136:1997;57-65.
12. Faure E., Gouédard L., Imbeaud S., Cate R.L., Picard J.Y., Josso N., di Clemente N. Mutant isoforms of the anti-Müllerian hormone type II receptor are not expressed at the cell membrane. J. Biol. Chem. 271:1996;30571-30575.
13. Gouédard L., Chen Y.G., Thevenet L., Racine C., Borie S., Lamarre I., Josso N., Massagué J., di Clemente N. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. J. Biol. Chem. 275:2000;27973-27978.
14. Gu Z.Y., Reynolds E.M., Song J.H., Lei H., Feijen A., Yu L.A., He W.W., MacLaughlin D.T., van den Eijnden van Raaij J., Donahoe P.K., Li E. The type I serine threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development. 126:1999;2551-2561.
15. Henningfeld K.A., Rastegar S., Adler G., Knöchel W. Smad1 and Smad4 are components of the Bone Morphogenetic Protein-4 (BMP-4)-induced transcription complex of the Xvent-2B promoter. J. Biol. Chem. 275:2000;21827-21835.
16. Imbeaud S., Faure E., Lamarre I., Mattei M.G., di Clemente N., Tizard R., Carré-Eusèbe D., Belville C., Tragethon L., Tonkin C., Nelson J., McAuliffe M., Bidart J.M., Lababidi A., Josso N., Cate R.L., Picard J.Y. Insensitivity to anti-Müllerian hormone due to a spontaneous mutation in the human anti-Müllerian hormone receptor. Nat. Genet. 11:1995;382-388.
17. Jamin S.P., Arango N.A., Mishina Y., Hanks M.C., Behringer R.R. Requirement of BMPR-IA for Müllerian duct regression during male sexual development. Nat. Genet. 32:2002;408-410.
18. Josso, N., Picard, J.Y., Rey, R., 1999. Retained Müllerian ducts: AMH resistance syndrome. In: Jameson, J.L. (Ed.), Hormone Resistance Syndromes. Humana Press, Towota, New Jersey, pp. 233-244.
19. Josso N., Racine C., di Clemente N., Rey R., Xavier F. The role of anti-Müllerian hormone in gonadal development. Mol. Cell. Endocrinol. 145:1998;3-7.
20. Massagué J., Chen Y.G. Controlling TGF-β signaling. Gene. Dev. 14:2000;627-644.
21. Massagué J., Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:2000;1745-1754.
22. Messika-Zeitoun L., Gouédard L., Belville C., Dutertre M., Lins L., Imbeaud S., Hughes I.A., Picard J.Y., Josso N., di Clemente N. Autosomal recessive segregation of a truncating mutation of anti-Müllerian hormone type II receptor in a family affected by the persistent Müllerian duct syndrome contrasts with its dominant negative activity in vitro. J. Clin. Endocrinol. Metab. 86:2001;4390-4397.
23. Mishina Y., Crombie R., Bradley A., Behringer R.R. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev. Biol. 213:1999;314-326.
24. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway. Genes Dev. 10:1996;2577-2587.
25. Mulsant P., Lecerf F., Fabre S., Schibler L., Monget P., Lanneluc I., Pisselet C., Riquet J., Monniaux D., Callebaut I., Cribiu E., Thimonier J., Teyssier J., Bodin L., Cognie Y., Chitour N., Elsen J.M. Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merino ewes. Proc. Nat. Acad. Sci. U.S.A. 98:2001;5104-5109.
26. Racine C., Rey R., Forest M.G., Louis F., Ferré A., Huhtaniemi I., Josso N., di Clemente N. Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;594-599.
27. Segev D.L., Ha T.U., Tran T.T., Kenneally M., Harkin P., Jung M., MacLaughlin D.T., Donahoe P.K., Maheswaran S. Mullerian inhibiting substance inhibits breast cancer cell growth through an NF kappa B-mediated pathway. J. Biol. Chem. 275:2000;28371-28379.
28. Tang S.J., Hoodless P.A., Lu Z., Breitman M.L., McInnes R.R., Wrana J.L., Buchwald M. The Tlx-2 homeobox gene is a downstream target of BMP signalling and is required for mouse mesoderm development. Development. 125:1998;1877-1888.
29. Visser J.A., Olaso R., Verhoef-Post M., Kramer P., Themmen A.P.N., Ingraham H.A. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol. Endocrinol. 15:2001;936-945.
30. Yi S.E., LaPolt P.S., Yoon B.S., Chen J.Y.C., Lu J.K.H., Lyons K.M. The type I BMP receptor BmprIB is essential for female reproductive function. Proc. Natl. Acad. Sci. U.S.A. 98:2001;7994-7999.